Skip to main content

Table 2 Days of sick leave due to respiratory and gastrointestinal diseases within the 90 days of observation

From: Effects of the regular intake of the probiotic Lactobacillus reuteri (DSM 17938) on respiratory and gastrointestinal infections in a workplace setting: a double-blind randomized placebo-controlled trial

 

Intervention group

Control group

 

(n = 79)

(n = 80)

Total number of days under observation

7,110

7,200

Total number of days of sick leave due to respiratory and gastrointestinal diseases

176.9

161.5

Number of days of sick leave as a percentage of the days under observation

2.49%

2.24%

Number of days of sick leave per participant

  

  Mean

2.24

2.02

  Standard deviation

4.74

4.28

  Minimum

0

0

  Maximum

30

24

Number of participants with at least one day of sick leave during the intervention period

28 (35.4%)

24 (30.0%)

Number of days of sick leave for participants with at least one day of sick leave

  

  Median

5.0

5.0

  Mean

6.32

6.73

  Standard deviation

6.19

5.45

  Minimum

1

1

  Maximum

30

24